Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Eucalyptus camaldulensis</i> Extract Mediated Green Synthesis of Iron Oxide Nanoparticles and In Vitro and In Vivo Biological Screening, and Detailed Molecular Docking Analysis.

Food science & nutrition·2026
Same author

Coaxially extruded Ag/chitosan-ZnO macrotubes for efficient dyes removal in real water samples.

International journal of biological macromolecules·2026
Same author

Nosema ceranae and honey bee-associated virus levels in commercial beekeeping operations across Southwestern Saudi Arabia.

Journal of invertebrate pathology·2026
Same author

Schwannoma of tongue: a clinicopathologic study of 34 cases and review of published literature.

Diagnostic pathology·2026
Same author

Osteocalcin Beyond Bone: Molecular Mechanisms, Endocrine Networks, and Translational Perspectives Across Metabolism, Neurobiology, and Chronic Disease.

International journal of molecular sciences·2026
Same author

The New Era of Precision Oncology. Practicing Pathology in Low Resource Countries and Settings.

International journal of general medicine·2026

Related Experiment Video

Updated: Jul 5, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Dubin-Johnson syndrome.

Aziz-un Nisa1, Zubair Ahmad

  • 1Department of Pathology and Microbiology, The Aga Khan University Hospital, Karachi.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|May 8, 2008
PubMed
Summary

Dubin-Johnson syndrome is a benign genetic disorder causing recurrent jaundice due to impaired bilirubin transport. This condition, characterized by dark liver pigment, requires no treatment and has a normal life expectancy.

Area of Science:

  • Hepatology
  • Medical Genetics

Background:

  • Dubin-Johnson syndrome is an inherited disorder affecting bilirubin metabolism.
  • It is characterized by recurrent episodes of conjugated hyperbilirubinemia and mild jaundice.

Observation:

  • A young male patient presented with recurrent mild jaundice.
  • Liver function tests were normal except for elevated conjugated bilirubin.
  • Liver biopsy revealed characteristic dark brown pigment deposition in hepatocytes.

Findings:

  • The syndrome results from a defect in the canalicular protein MRP2 (multidrug resistance-associated protein 2).
  • This defect impairs the biliary secretion of conjugated bilirubin and other organic anions.
  • Genetic analysis identified the MRP2 defect on chromosome 10q24.

Related Experiment Videos

Last Updated: Jul 5, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Implications:

  • Dubin-Johnson syndrome is a benign condition with no long-term health consequences.
  • Patients typically have a normal life expectancy and do not require specific medical treatment.
  • Accurate diagnosis through liver biopsy and genetic testing is crucial for patient management.